A. Dirican Et Al. , "Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer," MEDICAL ONCOLOGY , vol.31, no.4, 2014
Dirican, A. Et Al. 2014. Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. MEDICAL ONCOLOGY , vol.31, no.4 .
Dirican, A., Kucukzeybek, Y., Alacacioglu, A., Varol, U., Aksun, S., Bayoglu, I. V., ... DEMİR, L.(2014). Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. MEDICAL ONCOLOGY , vol.31, no.4.
Dirican, Ahmet Et Al. "Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer," MEDICAL ONCOLOGY , vol.31, no.4, 2014
Dirican, Ahmet Et Al. "Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer." MEDICAL ONCOLOGY , vol.31, no.4, 2014
Dirican, A. Et Al. (2014) . "Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer." MEDICAL ONCOLOGY , vol.31, no.4.
@article{article, author={Ahmet Dirican Et Al. }, title={Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer}, journal={MEDICAL ONCOLOGY}, year=2014}